ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| InnoCan Pharma Corporation | INNO | Canada | — | 452 |
| Novan Inc Delisted | NOVN | United States of America | — | 451 |
| Kolon TissueGene, Inc. | 950160 | South Korea | — | 449 |
| OTONOMY, INC. Delisted | — | United States of America | — | 449 |
| PreveCeutical Medical | PREV | Canada | — | 446 |
| CHOSA Oncology AB | CHOSA | Sweden | — | 445 |
| BioNxt Solutions Inc. | BNXT | Canada | — | 444 |
| Pfenex Inc Delisted | PFNX | United States of America | — | 442 |
| Tapestry Pharmaceuticals Inc Delisted | TPPHQ | United States of America | — | 442 |
| Euthymics Bioscience, Inc. Delisted | — | United States of America | — | 440 |
| MYOGEN INC Delisted | — | United States of America | — | 440 |
| NEUROBIOLOGICAL TECHNOLOGIES INC Delisted | — | United States of America | — | 440 |
| BrightPath Biotherapeutics Co., Ltd. | 4594 | Japan | — | 439 |
| HINOVA PHARMACEUTICALS INC. | 688302 | China | — | 438 |
| GENELABS TECHNOLOGIES INC Delisted | — | United States of America | — | 437 |
| Gritstone Oncology Inc Delisted | GRTS | United States of America | — | 437 |
| Sirnaomics Ltd. | 2257 | Cayman Islands | — | 437 |
| Renovis Inc Delisted | RNVS | United States of America | — | 434 |
| Achaogen Inc Delisted | AKAO | United States of America | — | 433 |
| Harpoon Therapeutics Inc Delisted | HARP | United States of America | — | 433 |
| ORE PHARMACEUTICAL HOLDINGS INC. Delisted | — | United States of America | — | 431 |
| Pharmasset Inc Delisted | — | United States of America | — | 431 |
| BioVaxys Technology Corp. | BIOV | Canada | — | 430 |
| GI Innovation Inc. | 358570 | South Korea | — | 430 |
| ISLAND PHARMACEUTICALS LIMITED | ILA | Australia | — | 430 |
| NurExone Biologic Inc | NRX | Canada | — | 430 |
| Aptose Biosciences Inc. | APS | Canada | — | 429 |
| Mountain Valley MD Holdings Inc. | MVMD | Canada | — | 429 |
| Revive Therapeutics Ltd. | RVV | Canada | — | 429 |
| Sona Nanotech Inc. | SONA | Canada | — | 429 |
| Iteos Therapeutics Inc Delisted | ITOS | United States of America | — | 428 |
| NEOPHARM INC Delisted | — | United States of America | — | 427 |
| Lobe Sciences Ltd. | LOBE | Canada | — | 425 |
| TENGION INC Delisted | — | United States of America | — | 425 |
| Kythera Biopharmaceuticals Inc Delisted | KYTH | United States of America | — | 421 |
| MultiCell Technologies, Inc. Delisted | — | United States of America | — | 421 |
| SunBio, Inc. | 067370 | South Korea | — | 421 |
| AbClon Inc. | 174900 | South Korea | — | 420 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD | NSB | Australia | — | 420 |
| Pathfinder Cell Therapy, Inc. Delisted | — | United States of America | — | 420 |
| Provention Bio Inc Delisted | PRVB | United States of America | — | 420 |
| CANNABIS SCIENCE, INC. Delisted | — | United States of America | — | 418 |
| Psyence Group Inc. | PSYG | Canada | — | 418 |
| WPD Pharmaceuticals Inc. | WBIO | Canada | — | 418 |
| KOSAN BIOSCIENCES INC Delisted | KOSN | United States of America | — | 417 |
| Innoveren Scientific, Inc. Delisted | — | United States of America | — | 416 |
| Neurotrope Inc Delisted | NTRP_old | United States of America | — | 416 |
| Juno Therapeutics Inc Delisted | JUNO | United States of America | — | 414 |
| Kite Pharma Inc Delisted | KITE | United States of America | — | 413 |
| Jounce Therapeutics Inc Delisted | JNCE | United States of America | — | 412 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.